Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Ribometrix

Ribometrix

Small molecule drugs that target functional 3D RNA structures to treat human diseases.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

November 13, 2018
Ribometrix raises a $30,000,000 series A round.
November 2017
Ribometrix raises a $7,500,000 seed round from AbbVie Inc., Dementia Discovery Fund, Hatteras Venture Partners, MP Healthcare Venture Management and SV Health Investors.
October 31, 2017
Ribometrix raises a $7,500,000 seed round from SV Health Investors.

Funding Rounds

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Alex Keown
July 2, 2021
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
BioSpace
June 28, 2021
BioSpace
Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced the appointment of Manjunath Ramarao, Ph.D., as senior vice president in its research and development team.

References

Golden logo
By using this site, you agree to our Terms & Conditions.